In pregnant women with sickle cell disease, the risk of developing early-onset preeclampsia can be determined by measuring ...
A second blood test has been been approved by the US Food and Drug Administration to assist in diagnosing Alzheimer’s disease ...
In pregnant women with sickle cell disease, the risk of developing early-onset preeclampsia can be determined by measuring ...
Syncell Inc. announced the deployment of its commercial Microscoop® Mint technology at two of Europe’s foremost research ...
Race-neutral pulmonary function testing, now recommended by ATS and implemented at Boston Medical Center, has had a long road ...
The recommendations aim to reduce unnecessary ‘cumbersome’ testing and improve antibiotic stewardship in sore throat ...
News Medical on MSN
Biomarker Predicts Preeclampsia Risk in Sickle Cell
October 21, 2025) – In pregnant women with sickle cell disease, the risk of developing early-onset preeclampsia can be determined by ...
Professor Clare Turnbull, Professor of Translational Cancer Genetics at The Institute of Cancer Research, London, said: ...
Correspondence to Dr Natalia Khalaf; natalia.khalaf@bcm.edu ...
A new rapid test for COVID-19 has over 99% diagnostic sensitivity in early studies, scientists assessing the test at the University of Oxford said on Friday.
Objective Macrophage activation syndrome (MAS), a subtype of secondary haemophagocytic lymphohistiocytosis (HLH), is a rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback